Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2005
10/27/2005US20050239730 Plasmodium falciparum erythrocyte binding protein baebl for use as a vaccine
10/27/2005US20050239729 Incorporating the pro-apoptotic protein BAX and autoantigens adenoviral protein E3-GP19k and Delta BCL-2 into an injectable antidiabetic or hypoglycemic formulation; prevention, diagnosis and monitoring of diabetic patients
10/27/2005US20050239711 Selective linear peptides with melanocortin-4 receptor (MC4-R) agonist activity
10/27/2005US20050239710 Peptide that inhibits matrix metalloproteinase-2; incorporated into lotion or wound dressing; can promote the growth of fibroblasts, prevent skin wrinkling, treat scarring, promote smooth healthy skin
10/27/2005US20050239709 Synthetic antimicrobial polypeptides
10/27/2005US20050239708 Use of factor VIIa or a tissue factor antagonist for regulating gene expression and cell migration or chemotaxis
10/27/2005US20050239704 Modulation gene expression, drug screening assays, for use as anti-bacterial agents
10/27/2005US20050239702 Methods of modulating FabH activity
10/27/2005US20050239699 Remedy for infections
10/27/2005US20050239696 Gmg-3 gmg-4 and gmg-6 polynucleotides and polypeptides and uses thereof
10/27/2005US20050239684 Compounds which inhibit beta-secretase activity and methods of use thereof
10/27/2005US20050239209 Method for peptide and polypeptide purification and differential analysis
10/27/2005US20050239205 Gb virus b based replicons and replicon enhanced cells
10/27/2005US20050239204 Multifunctional molecular complexes for gene transfer to cells
10/27/2005US20050239187 Methods to culture circovirus
10/27/2005US20050239177 Novel gene and method for producing L-amino acids
10/27/2005US20050239176 Genes for heat resistant enzymes of amino acid biosynthetic pathway derived from thermophilic coryneform bacteria
10/27/2005US20050239172 Methods and DNA constructs for high yield production of polypeptides
10/27/2005US20050239171 Method for purifying factor VIII/vWF-complex by means of cation exchange chromatography
10/27/2005US20050239170 Alpha-MSH related compounds and methods of use
10/27/2005US20050239169 Nucleotide sequences coding seladin-1polypeptide for use in treatment and prevention of alzheimer's disease
10/27/2005US20050239167 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide
10/27/2005US20050239166 Polynucleotides encoding human secreted protein, ZZP1
10/27/2005US20050239163 Cloning, expression and functional characterization of a mammalian DNA-R gene; polypetide having amino acid sequence with deletion at 1133 1171 amino acids
10/27/2005US20050239160 Method for identification of proteins from intracellular bacteria
10/27/2005US20050239141 Modified antibody variable domains
10/27/2005US20050239138 Use of cardiac hormones to assess risk of cardiovascular complication from volume overload
10/27/2005US20050239135 Compositions, methods and kits for biarsenical fluorophore labeling
10/27/2005US20050239134 Combinatorial selection of phosphorothioate single-stranded DNA aptamers for TGF-beta-1 protein
10/27/2005US20050239130 Method for identifying a modulator of the binding of CCX CKR polypeptide to a chemokine
10/27/2005US20050239123 Human tumor necrosis receptor TR9
10/27/2005US20050239121 Non-aggregating non-quenching oligomers comprising nucleotide analogs; methods of synthesis and use thereof
10/27/2005US20050239105 NOD2 nucleic acids and proteins
10/27/2005US20050239103 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
10/27/2005US20050239099 27 human secreted proteins
10/27/2005US20050239098 Novel hyaluronan-binding proteins and encoding genes
10/27/2005US20050239094 Compositions and methods for inducing and regulating bone formation
10/27/2005US20050239093 Toll-like receptor
10/27/2005US20050239088 Intron fusion proteins, and methods of identifying and using same
10/27/2005US20050239081 Polymerase enhancing factor (PEF) extracts, PEF protein complexes, isolated PEF protein, and methods for purifying and identifying
10/27/2005US20050239072 Device and methods for concentrating prion protein isoforms
10/27/2005US20050239070 Neopeptides and methods useful for detection and treatment of cancer
10/27/2005US20050239069 which influence haemoglobin formation in neuronal, myocardial and/or skeletomuscular cells; gene therapy
10/27/2005US20050239068 Method for isolating nucleic acids and protein from a single sample
10/27/2005US20050239065 Formed by splicing, genetic deletions, point mutations; vectors; host cells
10/27/2005US20050239064 Methods and compositions based on protein interactions with mastermind
10/27/2005US20050239060 Expression vector comprising nucleotide sequences coding protein factor for treatment, diagnosis and prevention of proliferative and differentiative disorders
10/27/2005US20050239059 67 human secreted proteins
10/27/2005US20050239052 Cloning of rhadinovirus genome and methods for its use
10/27/2005US20050238723 Method of producing hydroxyalkyl starch derivatives
10/27/2005US20050238685 Method of binding a compound to a surface
10/27/2005US20050238669 Animal product free system and process for purifying a botulinum toxin
10/27/2005US20050238668 Media for clostridium bacterium and processes for obtaining a clostridial toxin
10/27/2005US20050238665 Soluble recombinant botulinum toxin proteins
10/27/2005US20050238662 Immunogens; water-in-oil emulsions; oil-in-water emulsions; vaccines; freeze drying
10/27/2005US20050238661 Infectious cDNA clones of porcine reproductive and respiratory syndrome virus and expression vectors thereof
10/27/2005US20050238657 Defective entities and uses therefor
10/27/2005US20050238656 Recombinant vesiculoviruses and their uses
10/27/2005US20050238653 Pharmaceutical compositions containing extracted MHC molecules, for stimulation of the immune system
10/27/2005US20050238652 Human lung adenocarcinoma-related monoclonal antibody and antigen and immunaossay method which uses the same
10/27/2005US20050238648 Composition and method for trating inflammatory disorders
10/27/2005US20050238647 Therapeutic uses for MDC and MDC antagonists
10/27/2005US20050238642 Modified bouganin proteins, cytotoxins and methods and uses thereof
10/27/2005US20050238624 Insulin-like growth factor (IGF-I) plasmid-mediated supplementation for therapeutic applications
10/27/2005US20050238617 Methods for increasing protein polyethylene glycol (PEG) conjugation
10/27/2005US20050238607 FGF-5 supported and binding peptides
10/27/2005US20050238582 Administering a conjugate of a a cell and a light-generating moiety; and measuring photon emission through an opaque tissue of said mammalian subject from the light-generating moiety; used for tracking the progression of infection
10/27/2005US20050238579 Human g protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure
10/27/2005DE19964269B4 Verfahren zur Detektion des Proliferationspotentials von Zellen A process for the detection of the proliferation potential of cells
10/27/2005CA2786794A1 Prodrug linker
10/27/2005CA2564878A1 Therapeutic heparins and their binding to interleukins 4 and 5, and pecam-1
10/27/2005CA2563578A1 Diagnostic and therapeutic applications of soluble lhcgr protein
10/27/2005CA2563390A1 Compounds that block the c5a receptor and their use in therapy
10/27/2005CA2563332A1 Therapeutic uspa1-derived peptides
10/27/2005CA2563284A1 Canine cold-and menthol-sensitive receptor 1
10/27/2005CA2563266A1 Kluyveromyces lactis promoter variants lacking e. coli transcriptional capability
10/27/2005CA2562892A1 Bob-1 specific t cells and methods to use
10/27/2005CA2562885A1 Follistatin variant polypeptide
10/27/2005CA2562881A1 Novel monkey gpr103 and monkey qrfp and method of evaluating compound by using gpr103
10/27/2005CA2562784A1 Fluorocarbon antigen delivery vectors and constructs
10/27/2005CA2562766A1 Purified interleukin-15/fc fusion protein and preparation thereof
10/27/2005CA2562761A1 Expression system for preparing il-15/fc fusion proteins and its use
10/27/2005CA2562520A1 Dual-transfected cells lines as in vitro screening tools for pharmaceutical compound profiling: a model for heptobiliary elimination
10/27/2005CA2562193A1 Treatment of neuropathic pain with zinc finger proteins
10/27/2005CA2561830A1 Monoclonal antibodies with specificity for fetal erythroid cells
10/27/2005CA2561565A1 Methods for repression of phospholamban gene and modulating cardiac contractility
10/27/2005CA2560205A1 Fungal promoters for expressing a gene in a fungal cell
10/26/2005EP1589341A2 Method of selective peptide isolation for the identification and quantitative analysis of proteins in complex mixtures
10/26/2005EP1589115A2 Polymorphisms of the human organic anion transporting polypeptide-C (OATP-C)
10/26/2005EP1589111A1 Recombinant hepatitis a virus antigens obtained in plant cells
10/26/2005EP1589109A2 VMP-like sequences of pathogenic borrelia
10/26/2005EP1589108A2 Methods and reagents for vaccination which generate a CD8 T cell immune response
10/26/2005EP1589107A1 Immunoglobulins devoid of light chains
10/26/2005EP1589106A1 Adiponectin receptor and gene coding for the same
10/26/2005EP1589103A1 Method of screening agent for improving memory and learning ability
10/26/2005EP1589101A1 Novel protein and its gene
10/26/2005EP1589100A1 Transcriptional activator
10/26/2005EP1589096A1 Method for producing L-amino acid
10/26/2005EP1589034A2 Rationally designed antibodies
10/26/2005EP1589032A1 Genetically-modified yeasts which can float in a liquid medium, production method thereof and use of same
1 ... 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 ... 2916